BRIEF published on 04/10/2025 at 20:52, 7 months 24 days ago Hinkel & Cie. GmbH Secures Approval for Bond Amendments Creditors' Meeting Financial Restructuring Bond Amendment Hinkel & Cie. Qualified Majority
PRESS RELEASE published on 04/10/2025 at 20:47, 7 months 24 days ago EQS-Adhoc: Hinkel & Cie. GmbH: first creditors´meeting of the bond DE000A2AAPX4 Hinkel & Cie. GmbH announces successful amendment of bond terms by qualified majority at first creditors' meeting for bond DE000A2AAPX4 Bond Amendment Creditors' Meeting Hinkel & Cie. GmbH Qualified Majority
BRIEF published on 03/14/2025 at 20:25, 8 months 21 days ago Hinkel & Cie. GmbH Proposes Bond Term Extension Market Challenges Creditors' Meeting Bond Extension Business Flexibility Hinkel & Cie. GmbH
PRESS RELEASE published on 03/14/2025 at 20:20, 8 months 21 days ago EQS-Adhoc: Gläubigerversammlung zur Anleihenverlängerung Hinkel & Cie. GmbH announces proposed extension of bond term to March 31, 2029, due to market conditions. Vote expected in mid-March 2025 Market Conditions Creditors Vote Bond Extension Hinkel & Cie. GmbH
Published on 12/05/2025 at 02:35, 3 hours 30 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 5 hours 5 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 5 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 03:30, 2 hours 34 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 14 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 39 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 50 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 54 minutes ago SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance
Published on 12/04/2025 at 18:00, 12 hours 5 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 20 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 21 minutes ago Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 4 minutes ago bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago Declaration of voting rights at the end of November 2025
